MOLCURE Inc
Molcure is a high-speed, high-quality, high-variation antibody screening &a; design system combining biology, automation and bioinformatics
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed MOLCURE Inc Information
Geographic Data
Address:
City: Tokyo
State: Tokyo
Zip:
Country: Japan
Financial Info
Stage:
series c
Raised Last:
$7M
Raised Total:$12M
Social
Metrics
3,555,390Website Global Rank
3,868Website Monthly Traffic
Twitter Followers
Description
Molcure is antibody and Peptide drug-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of patients by developing and providing more effective therapeutics and supportive care products. Molcure represents high quality antibody and target discovery. With cutting edge technology in-house, Molcure is the partner of choice for therapeutic antibody discovery. At Molcure they combine a deep knowledge of NGS, bioinformatics and antibody biology with automated discovery system. The antibody discovery platform Abtracer delivers superior functional antibodies. Their technology is validated through a number of partnerships. They are seeking new partnership opportunities.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Series B | 3 | $2.7M |
Dai-ichi Life GMO VenturePartners Nippon Chemiphar Dai-ichi Life GMO VenturePartners Nippon Chemiphar |
8/2021 | Series C | $0 |
GMO VenturePartners JAFCO Group Japan Post Capital Nippon Chemiphar SBI Investment STRIVE GMO VenturePartners JAFCO Group Japan Post Capital Nippon Chemiphar SBI Investment STRIVE |
2/2013 | Debt Financing | $106.7k | 7/2013 | Seed Round | $34.6k | 10/2014 | Series A | 1 | $1.8M |
UTEC - The University of Tokyo Edge Capital Partners UTEC - The University of Tokyo Edge Capital Partners |
7/2013 | Seed Round | $10.2k | 6/2013 | Angel Round | $0 |
Synclogue Synclogue |
8/2021 | Series C | 6 | $7.3M |
GMO VenturePartners JAFCO Group Japan Post Capital Nippon Chemiphar SBI Investment STRIVE GMO VenturePartners JAFCO Group Japan Post Capital Nippon Chemiphar SBI Investment STRIVE |
6/2013 | Angel Round | 1 | $46.3k |
Synclogue Synclogue |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
